PSIP1 and posterior cortical atrophy: Additional studies targeting LEDGF/p75 and its interacting partners with small molecule inhibitors, individually and in combination, in both cell-derived and patient-derived xenograft models of DTX resistance, are guaranteed to determine the therapeutic potential of targeting this interactome for overcoming PCa chemoresistance in the clinic.